Home
/
NEOGENOMICS INC
/
Financials
/
Quarterly
NEOGENOMICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NEOGENOMICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$67.75M
Aug 6, 2018
Q1
2018
Mar 31, 2018
$63.42M
May 8, 2018
Q2
2018
Jun 30, 2017
$62.26M
Aug 6, 2018
Q1
2018
Mar 31, 2017
$57.43M
May 8, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($27.13M)
Oct 28, 2025
Q3
2025
Jun 30, 2025
($45.09M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
($45.09M)
Jul 29, 2025
Q2
2025
Mar 31, 2025
($25.92M)
Jul 29, 2025
Q3
2025
Mar 31, 2025
($25.92M)
Oct 28, 2025
Q1
2025
Mar 31, 2025
($25.92M)
Apr 29, 2025
Q3
2025
Sep 30, 2024
($17.70M)
Oct 28, 2025
Q3
2025
Jun 30, 2024
($18.64M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($18.64M)
Jul 29, 2025
Q2
2025
Mar 31, 2024
($27.06M)
Jul 29, 2025
Q1
2025
Mar 31, 2024
($27.06M)
Apr 29, 2025
Q3
2025
Mar 31, 2024
($27.06M)
Oct 28, 2025
Q3
2024
Sep 30, 2023
($18.52M)
Nov 5, 2024
Q3
2024
Jun 30, 2023
($24.33M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($24.33M)
Jul 30, 2024
Q2
2024
Mar 31, 2023
($30.80M)
Jul 30, 2024
Q3
2024
Mar 31, 2023
($30.80M)
Nov 5, 2024
Q1
2024
Mar 31, 2023
($30.80M)
Apr 30, 2024
Q3
2023
Sep 30, 2022
($36.85M)
Nov 6, 2023
Q3
2023
Jun 30, 2022
($35.30M)
Nov 6, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($27.01M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
($47.63M)
Jul 29, 2025
Q1
2025
Mar 31, 2025
($27.83M)
Apr 29, 2025
Q3
2025
Sep 30, 2024
($21.20M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($21.94M)
Jul 29, 2025
Q1
2025
Mar 31, 2024
($30.57M)
Apr 29, 2025
Q3
2024
Sep 30, 2023
($24.20M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($29.89M)
Jul 30, 2024
Q1
2024
Mar 31, 2023
($35.07M)
Apr 30, 2024
Q3
2023
Sep 30, 2022
($39.51M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($39.70M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($52.03M)
May 9, 2023
Q3
2022
Sep 30, 2021
($39.71M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($22.37M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($15.11M)
May 9, 2022
Q3
2021
Sep 30, 2020
$4.67M
Nov 4, 2021
Q2
2021
Jun 30, 2020
($18.91M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
($5.29M)
May 6, 2021
Q3
2020
Sep 30, 2019
$3.66M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$4.48M
Jul 31, 2020